Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

https://www.soho2019.com/

 

Therapeutic Innovations in CML: Reducing Toxicity w/ Optimized Frontline Dosing or Programmed Dose Reductions, New ABL1 TKI Asciminib Is Very Promising

November 18, 2019

0 Comments
Login to view comments. Click here to Login